Grace Therapeutics, Inc. (GRCE) Financials
GRCE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 66.7 million | 2.8 million |
| Dec. 31, 2025 | 68.5 million | 3.6 million |
| Sept. 30, 2025 | 66.6 million | 3.8 million |
| June 30, 2025 | 69.8 million | 6.3 million |
GRCE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -1.7 million | -24000 |
| Dec. 31, 2025 | -2.2 million | 314000 |
| Sept. 30, 2025 | -3.2 million | 206000 |
| June 30, 2025 | -1.8 million | 302000 |
GRCE Net Income
No data available :(
GRCE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 17.0 million | - | - |
| Dec. 31, 2025 | 18.7 million | - | - |
| Sept. 30, 2025 | 16.9 million | - | - |
| June 30, 2025 | 20.0 million | - | - |
GRCE Shares Outstanding
GRCE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 420000 | 308589 | - |
| Dec. 31, 2025 | - | 633924 | 2.7 million | - |
| Sept. 30, 2025 | - | 792206 | 2.7 million | - |
| June 30, 2025 | - | 955000 | 2.1 million | - |
GRCE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 2000 |
| Dec. 31, 2025 | - | 4116 |
| Sept. 30, 2025 | - | 2000 |
| June 30, 2025 | - | 2000 |
GRCE
Price: $2.33
52 week price:
Earnings Per Share: -0.47 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 40.2 million